Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 12, 2001, Pages 2059-2064

  Jones, Steven P ^a   Trocha, Steven D ^a   Lefer, David J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Contractile function; Infarct; Inflammation; Nitric oxide

Indexed keywords

NITRIC OXIDE SYNTHASE; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FILLING; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; MOUSE; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035572838     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq1201.099509     Document Type: Article

References (35)

1. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
3. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month
4. Vascular effects of HMG-CoA reductase inhibitors (statins) unrelated to cholesterol lowering: New concepts for cardiovascular disease
5. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering
6. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts
7. HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury
8. Simvastatin exerts both anti-inflammatory and cardioprotective effects in apoE deficient mice
9. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
10. Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury
11. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion
12. Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury
13. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion
14. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs
15. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase
16. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice
17. Role of leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury
18. Myocardial ischemia-reperfusion injury in NADPH oxidase deficient mice
19. PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice
20. Myocardial reperfusion injury in nNOS deficient mice
21. Acute exposure to a high cholesterol diet attenuates myocardial ischemia-reperfusion injury in cholesteryl ester transfer protein mice
22. Cardioprotective actions of endogenous IL-10 are independent of iNOS
23. Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse
24. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion
25. Evidence against the "early protection-delayed death" hypothesis of superoxide dismutase therapy in experimental myocardial infarction: Polyethylene glycol-superoxide dismutase plus catalase does not limit myocardial infarct size in dogs
26. Superoxide dismutase conjugated to polyethylene glycol fails to limit myocardial infarct size after 30 min ischemia followed by 72 h of reperfusion in the rabbit
27. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase
28. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-I and endothelial nitric oxide synthase in vascular endothelial cells
29. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
30. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
31. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
32. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats
33. A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels
34. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering